Menu

Vertex Pharmaceuticals Incorporated VRTX

Full chart Compare
Set alert

Price alert · VRTX

All alert types
547.09 USD +4.59 (+0.85%)

At closeNov 6, 2026, 5:55 PM EST

548.00 +0.91 +0.17%

After hours · Nov 6, 5:55 PM ET

531.53 Day range 548.76
409.47 52-week range 558.88
YTD
+20.67%
1 year
+31.43%

VRTX revenue history

Revenue is income from the company’s ordinary business activities.

12,001,300,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

FY 1994: 23,145,000USDFY 1995: 27,534,000USDFY 1996: 18,598,000USDFY 1997: 43,799,000USDFY 1998: 29,055,000USDFY 1999: 108,887,000USDFY 2000: 153,282,000USDFY 2001: 85,297,000USDFY 2002: 94,770,000USDFY 2003: 69,141,000USDFY 2004: 102,717,000USDFY 2005: 160,890,000USDFY 2006: 216,356,000USDFY 2007: 199,012,000USDFY 2008: 175,504,000USDFY 2009: 101,889,000USDFY 2010: 143,370,000USDFY 2011: 1,410,626,000USDFY 2012: 1,527,042,000USDFY 2013: 1,211,975,000USDFY 2014: 580,415,000USDFY 2015: 1,032,336,000USDFY 2016: 1,702,177,000USDFY 2017: 2,488,652,000USDFY 2018: 3,047,597,000USDFY 2019: 4,162,800,000USDFY 2020: 6,205,700,000USDFY 2021: 7,574,400,000USDFY 2022: 8,930,700,000USDFY 2023: 9,869,200,000USDFY 2024: 11,020,100,000USDFY 2025: 12,001,300,000USD

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-3112,001,300,000981,200,0008.90%
FY 20242024-12-3111,020,100,0001,150,900,00011.66%
FY 20232023-12-319,869,200,000938,500,00010.51%
FY 20222022-12-318,930,700,0001,356,300,00017.91%
FY 20212021-12-317,574,400,0001,368,700,00022.06%
FY 20202020-12-316,205,700,0002,042,900,00049.08%
FY 20192019-12-314,162,800,0001,115,203,00036.59%
FY 20182018-12-313,047,597,000558,945,00022.46%
FY 20172017-12-312,488,652,000786,475,00046.20%
FY 20162016-12-311,702,177,000669,841,00064.89%
FY 20152015-12-311,032,336,000451,921,00077.86%
FY 20142014-12-31580,415,000-631,560,000-52.11%
FY 20132013-12-311,211,975,000-315,067,000-20.63%
FY 20122012-12-311,527,042,000116,416,0008.25%
FY 20112011-12-311,410,626,0001,267,256,000883.91%
FY 20102010-12-31143,370,00041,481,00040.71%
FY 20092009-12-31101,889,000-73,615,000-41.94%
FY 20082008-12-31175,504,000-23,508,000-11.81%
FY 20072007-12-31199,012,000-17,344,000-8.02%
FY 20062006-12-31216,356,00055,466,00034.47%
FY 20052005-12-31160,890,00058,173,00056.63%
FY 20042004-12-31102,717,00033,576,00048.56%
FY 20032003-12-3169,141,000-25,629,000-27.04%
FY 20022002-12-3194,770,0009,473,00011.11%
FY 20012001-12-3185,297,000-67,985,000-44.35%
FY 20002000-12-31153,282,00044,395,00040.77%
FY 19991999-12-31108,887,00079,832,000274.76%
FY 19981998-12-3129,055,000-14,744,000-33.66%
FY 19971997-12-3143,799,00025,201,000135.50%
FY 19961996-12-3118,598,000-8,936,000-32.45%
FY 19951995-12-3127,534,0004,389,00018.96%
FY 19941994-12-3123,145,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-11-05T07:00:37.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.